Exploring the value of clinical pharmacy services for patients with diabetes in safety net settings.

Res Social Adm Pharm

Department of Pharmacy & Therapeutics, School of Pharmacy, University of Pittsburgh, Pittsburgh PA, USA.

Published: September 2014

Background: The role of the pharmacist in safety net settings has not been well studied, specifically in meeting unmet needs of vulnerable patients with diabetes.

Objectives: To identify unmet management and medication-related needs of patients with diabetes who are receiving care in two distinct underserved practices in Pittsburgh, PA.

Methods: Individual, semi-structured interviews with patients from a free clinic (FC) and a federally qualified community health center (FQHC) in Pittsburgh were conducted. Inclusion criteria included: adults at least 18 years old with uncontrolled diabetes (A1C > 7%) who received health care services from either the FC or the FQHC. Participants completed a short demographic survey and answered questions about their perceptions and attitudes in four thematic areas: (1) self-management of diabetes; (2) medication-related needs; (3) the role of the pharmacist in their care; and (4) how pharmacists can be better integrated in their diabetes management. Transcripts were analyzed using principles of Grounded Theory.

Results: Twenty-nine interviews were conducted: 15 participants were from the FC, and 14 were from the FQHC. Five main themes emerged from each site including: patients experience challenges managing their diabetes, patients identify the emotional struggle associated with living with diabetes, patients feel that they are "on their own" to care for their diabetes, patients desire a personal and caring relationship with their pharmacist, and patients value a pharmacist who is knowledgeable about diabetes care.

Conclusions: These results will help provide guidance to pharmacists working in safety net settings who are interested in expanding clinical pharmacy services for patients with diabetes.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.sapharm.2012.11.001DOI Listing

Publication Analysis

Top Keywords

patients diabetes
12
safety net
12
net settings
12
diabetes patients
12
patients
10
diabetes
10
clinical pharmacy
8
pharmacy services
8
services patients
8
role pharmacist
8

Similar Publications

Essential Thrombocythemia: A Review.

JAMA

January 2025

CRIMM, Center Research and Innovation of Myeloproliferative Neoplasms, University of Florence, AOU Careggi, Florence, Italy.

Importance: Essential thrombocythemia, a clonal myeloproliferative neoplasm with excessive platelet production, is associated with an increased risk of thrombosis and bleeding. The annual incidence rate of essential thrombocythemia in the US is 1.5/100 000 persons.

View Article and Find Full Text PDF

The underlying mechanisms of the association of bone health with depression - an experimental study.

Mol Biol Rep

January 2025

Medical Sociology and Psychobiology, Department of Health and Physical Activity, University of Potsdam, 14469, Potsdam, Germany.

Background: Depression constitutes a risk factor for osteoporosis, but underlying molecular and cellular mechanisms are not fully understood. MiRNAs influence gene expression and are carried by extracellular vesicles (EV), affecting cell-cell communication.

Aims: (1) Identify the difference in miRNA expression between depressed patients and healthy controls; (2) Analyze associations of these miRNAs with bone turnover markers; (3) Analyze target genes of differentially regulated miRNAs and predict associated pathways regarding depression and bone metabolism.

View Article and Find Full Text PDF

This study evaluated a next-generation automated insulin delivery (AID) algorithm for Omnipod in type 1 and type 2 diabetes across multiple phases: 14-day run-in with usual therapy, 48-h AID use in a hotel setting (type 1 only), and up to 6 weeks of outpatient AID use. Participants did, or did not, deliver manual boluses at alternating periods. Twelve adults with type 1 diabetes completed the hotel phase; 9 of those 12 plus 8 adults with type 2 diabetes completed the subsequent outpatient phase.

View Article and Find Full Text PDF

The triglyceride-glucose index as a surrogate measure to assess glycemic control in type 2 diabetes patients.

Ir J Med Sci

January 2025

Unidad de Investigación Biomédica, Delegación Durango, Instituto Mexicano del Seguro Social, Predio Canoas 100, Col. Los Angeles, Durango, 34077, México.

Background: It has been revealed that the potential utility of the triglycerides and glucose (TyG) index as an effective option for assessing glycemic control; however, evidence in this field is still scarce.

Aims: The goal of this study was to investigate the diagnostic accuracy of the TyG index, as an alternative option, to detect inadequate glycemic control in patients with type 2 diabetes (T2D).

Methods: Men and women between 30 and 60 years of age diagnosed with type 2 diabetes were included in a cross-sectional study.

View Article and Find Full Text PDF

Background: Worldwide trends support the increasing contribution of hepatic steatosis on the incidence of hepatocellular carcinoma (HCC). This study investigates if similar changes are seen in Hawaii, where the incidence of HCC is higher than most of the United States. Methods; This is a retrospective study of 1651 patients diagnosed with HCC (1991-2023) that includes 60-70% of Hawaii's HCC cases.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!